Molecular therapeutics of liver disease.
Fundamental advances in biomedical research will revolutionize the prevention and treatment of liver disease during the early twenty-first century. Recent progress in gene-, cell-, and recombinant protein-based therapeutics will contribute to this revolution, although formidable obstacles currently prevent the clinical application of these novel therapies. Eventually, these obstacles will be overcome, and molecular therapeutics of liver disease will become a clinical reality. As a result, the new millennium will be a very interesting time to practice hepatology.
Davern
T J
TJ
Division of Gastroenterology, University of California San Francisco, San Francisco, California, USA. tdavern@itsa.ucsf.edu
D000256:Adenoviridae; D000818:Animals; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D022781:Hepatocytes / Q000378:metabolism / Q000637:transplantation; D006801:Humans; D008107:Liver Diseases / Q000235:genetics* / Q000378:metabolism / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012190:Retroviridae
D011994:Recombinant Proteins